Microsoft word - emaco aps t2040.doc
Rapid setting repair mortar for industrial flooring DESCRIPTION
EMACO APS T2040 is a fast setting three-component
screedable patching mortar for floors utilising natural
aggregate and binder based on the new APS polymer
technology. It offers excel ent resistance against impact,
abrasion and scratching as wel as chemical attack.
EMACO APS T2040 is available in two types namely:
slow, and rapid version. They differ in their application
APS technology is a new and unique polymer technology
researched and developed by BASF Construction
Chemicals over the past 10 years and protected by
international patents. The APS technology is remarkable
in that a new base monomer was designed, synthesised
and registered by BASF Construction Chemicals as a new
chemical raw material. APS polymer technology has an
endless scope of possibilities of repair mortars, grouts,
adhesives, protective coatings etc. and making such
products faster to handle, safer to apply and simpler to
NB. Alkaline materials, may need evaluation. Refer BASF
Construction Chemicals Technical Consultants.
• food and beverage industry • cold stores
applicable at freezing temperatures (-25°C)
applicable at high temperatures (+40°C)
Al surfaces to be coated should be free from al oils,
contaminants, with a profile similar to medium sandpaper.
Mechanical preparatory techniques are more control able
Pre-condition products to temperature expected during
application, to achieve optimum work time. As
high resistance to chemical and mechanical
temperature drops under 0°C, cure period wil increase.
Material wil stiffen and be difficult to work in very cold
Mix Part A with Part B (ful kits only). Slowly add Part C and continue to mix until uniform. Ensure the final mix is
Pot life wil vary depending on the ambient temperature
lump free and even in colour. Al mixing should be done
using a slow speed dril (maximum rpm 600) and a spiral-
mixing paddle. Ensure al containers are completely
empty before disposal. Use ful kits only. When the
material is to be applied at thicknesses greater than 20mm, the addition of extra fil er is recommended. The
Cure time wil vary, dependent on the ambient
addition of fil er should be as below & added slowly to the
temperature. EMACO APS 2040 should be al owed to
cure for 2 - 6 hours protected from traffic and spil age.
The final surface may, for a 24 hour period, exhibit a
degree of residual 'tack'. This can be eliminated by
broadcasting with clear dry sand after application and
removing the sand before putting the area into service.
(+ 12.5kg of aggregate - 2-4mm) 50-100mm:
Uncured material may be removed using clean fresh water
and detergent. Cured material can only be removed
(+ 6.5kg aggregate - 2-4mm + 6.5kg aggregate - 8-16mm)
Al aggregates to be washed and kiln dried.
Apply the mortar by trowel to the prepared surface at the required thickness. The use of screed rails may be of
assistance. In instances of repair the edge of the repair
EMACO APS T2040 may be stored in tightly closed
should be square cut to a minimum of 3mm to avoid
feather edging. Compact and form as required. Do not
over trowel. Prime with a standard kit of EMACO APS T2040 when
For the ful health and safety hazard information and how to safely handle and use this product, please make sure that you obtain a copy of the BASF Material Safety Data Sheet (MSDS) from our office or our website.
The technical information and application advice given in this BASF publication are based on the present
state of our best scientific and practical knowledge. As the information herein is of a general nature, no assumption can be made as to a product's suitability for a particular use or application and no warranty as to
its accuracy, reliability or completeness either expressed or implied is given other than those required by law. The user is responsible for checking the suitability of products for their intended use. Field service where provided does not constitute supervisory responsibility. Suggestions made by
BASF either oral y or in writing may be fol owed, modified or rejected by the owner, engineer or contractor since they, and not BASF, are responsible for carrying out procedures appropriate to a specific application.
Head Office: 11 Stanton Road Seven Hil s, NSW 2147
45 Wil iam Pickering Drive, Albany, Auckland Ph: (09) 414 7233
Antibiotic Use in Veterinary Dentistry The management of bacterial infections and the use of antibiotics are complex subjects. This will be a brief discussion of some of the issues involved. The clinical decision to use or not use antibiotics in a particular case always resides with the attending veterinarian. What follows is my opinion. There are others with differing opinions. My observ
TOPIRAMATO 4.1.1 THERAPEUTIC 1. A reduction in seizure frequency and severity is indicative of therapeutic response totopiramate. E. BULIMIA NERVOSA - Topiramate was associated with a greater reduction in the mean weekly number of binge and/or purge days - Topiramate may have an effect on some behavioral - Topiramate improved binging and purging behavior in 3 out of 5 patients